# STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump

> **NCT07644247** · PHASE4 · NOT_YET_RECRUITING · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 370 (estimated)

## Conditions studied

- LVAD (Left Ventricular Assist Device) Thrombosis
- LVAD
- LVAD (Left Ventricular Assist Device)
- LVAD-related GI Bleed
- Bleeding
- Thrombosis
- Stroke
- Hemocompatibility-related Adverse Event
- Ventricular Assist Device
- Aspirin
- Antiplatelet Therapy
- Antithrombotic Therapy

## Interventions

- **DRUG:** Warfarin (INR 2-3) with placebo
- **DRUG:** Warfarin (INR 2-3) with aspirin

## Key facts

- **NCT ID:** NCT07644247
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-25
- **Primary completion:** 2029-01-01
- **Final completion:** 2029-12-31
- **Target enrollment:** 370 (ESTIMATED)
- **Last updated:** 2026-06-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07644247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07644247, "STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07644247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*